HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon Unveils Plan To Cut Debt As Q4 And Year End Loss Narrows

This article was originally published in The Rose Sheet

Executive Summary

Revlon has developed agreements with Fidelity Management and Research and MacAndrews & Forbes, the firm's principal shareholder owned by Chairman Ronald Perelman, that will reduce the color cosmetics marketer's debt by $930 mil., or approximately 50%, by March 31, 2006, the company reported Feb. 12

You may also be interested in...



Revlon Jumps Out Of The Red In Q4 With Net Income Of $46.2 Mil.

Revlon's efforts to improve its capital structure and grow operating income paid off in the fourth quarter, leading the firm's return to profitability for the first quarter in six years, the company announced during a March 8 analyst call

Revlon Jumps Out Of The Red In Q4 With Net Income Of $46.2 Mil.

Revlon's efforts to improve its capital structure and grow operating income paid off in the fourth quarter, leading the firm's return to profitability for the first quarter in six years, the company announced during a March 8 analyst call

Revlon Revised Outlook Calls For 3% Top-Line Growth

Revlon lowered its top and bottom line forecasts for the year in an announcement June 21, citing slow growth in the mass market color cosmetics category

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel